2 suspended. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Suspended 2 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BEN301 Injection in theTreatment of Autoimmune Diseases Single administration of 1x10^8 viable CD4+ CAR+ Foxp3+ cells., Single administration of 3x10^8 viable CD4+ CAR+ Foxp3+ cells. - Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA) | Early Phase 1 | Suspended | RenJi Hospital | 24 | 2026-04-20 | 2026-06-04 |
| Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases RD06-04 CART Cell Injection - Systemic Lupus Erythematosus, Systemic Sclerosis | Early Phase 1 | Suspended | Nanjing Bioheng Biotech Co., Ltd. | 12 | 2024-09-13 | 2026-02-03 |
Myositis (2) · Sjogren's Syndrome (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Lupus Erythematosus, Systemic (1)
Arthritis (2) · Connective Tissue Diseases (2) · Dry Eye Syndromes (2) · Eye Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Lacrimal Apparatus Diseases (2) · Mouth Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Rheumatic Diseases (2) · Salivary Gland Diseases (2) · Skin Diseases (2)
Nanjing Bioheng Biotech Co., Ltd. (1) · RenJi Hospital (1)
China (2)